The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission
Abstract
CONTEXT: Cushing's syndrome (CS) is associated with symptoms that may impair health-related quality of life (HRQL). METHODS: We used the short-form 36 survey to evaluate HRQL in 23 patients with Cushing's disease before and after transsphenoidal surgery (age, 42.7 +/- 12.0 yr; 19 women and four men) and in a cross-section of 343 CS patients (age, 48.2 +/- 14.1 yr; 265 women and 78 men) in remission for up to 25.8 yr after surgery (adrenal, 5%; ectopic, 6%). The z-scores were calculated for short-form 36 domains, and physical (PCS) and mental (MCS) summary scores were compared with those of age- and sex-matched controls (n = 6742). RESULTS: Active Cushing's disease was associated with low PCS and MCS scores (P < 0.05). Despite residual postoperative impairment, primarily of physical domains, all HRQL parameters improved after treatment with transsphenoidal surgery (3.2 +/- 1.5 yr; P < 0.05). In the cross-section in remission at follow-up, there was a small, but significant (P < 0.05), impairment of both PCS and MCS. A longitudinal postoperative analysis confirmed stable, but impaired, HRQL over time. Logistic regression demonstrated that previous pituitary radiation and current glucocorticoid use had little effect on HRQL outcomes. CONCLUSION: CS is associated with impaired HRQL, which partially resolves after treatment. At longer-term follow-up, however, there is residual impairment of HRQL. Determination of modifiable factors that contribute to impaired HRQL may help reduce the physical and psychosocial burden of this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among patients with CS, normalization of cortisol concentrations results in improvements in morbidity, mortality, and quality of life (28, 35, 109, 110).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [109]
Citations
Cites
Measuring Functioning and Well-Being: The Medical Outcomes Study Approach
Stewart, A., & Ware, J. (1992) · doi:10.7249/cb361 · Cited by 2,689
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Self-citationFaggiano, A., Pivonello, R., Spiezia, S., De Martino, M. C., Filippella, M., Di Somma, C., Lombardi, G., & Colao, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021558 · Cited by 358
Dorn, L. D., Burgess, E. S., Friedman, T. C., Dubbert, B., Gold, P. W., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3834 · Cited by 260
Quality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease
van Aken, M. O., Pereira, A. M., Biermasz, N. R., van Thiel, S. W., Hoftijzer, H. C., Smit, J. W. A., Roelfsema, F., Lamberts, S. W. J., & Romijn, J. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1375 · Cited by 251
Bourdeau, I., Bard, C., Noël, B., Leclerc, I., Cordeau, M., Bélair, M., Lesage, J., Lafontaine, L., & Lacroix, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8493 · Cited by 240
Quality of Life in Patients with a Pituitary Adenoma
Johnson, M. D., Woodburn, C. J., & Vance, M. L. (2003) · Pituitary · doi:10.1023/b:pitu.0000004798.27230.ed · Cited by 231
Elevated Cortisol Levels in Cushing’s Disease Are Associated With Cognitive Decrements
Starkman, M. N., Giordani, B., Berent, S., Schork, M. A., & SCHTEINGART, D. E. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200111000-00018 · Cited by 210
Long‐term negative impact on quality of life in patients with successfully treated Cushing's disease
Heald, A. H., Ghosh, S., Bray, S., Gibson, C., Anderson, S. G., Buckler, H. M., & Fowler, H. L. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02118.x · Cited by 175
Cited by
Sorted by citations
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
“Additionally, quality of life improves after surgical treatment but remains below that of age- and gendermatched subjects for up to 15 yr (18).”
BackgroundSelf-citationTreatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
Self-citationNewell-Price, J. D. C., BERTAGNA, X. Y., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,258
Self-citationLacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationValassi, E., Santos, A., Yaneva, M., Tóth, M., Strasburger, C. J., Chanson, P., Wass, J. A. H., Chabre, O., Pfeifer, M., Feelders, R. A., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0272 · Cited by 402
Androgen therapy in women: a reappraisal: an Endocrine Society Clinical Practice Guideline
Wierman, M. E., Arlt, W., Basson, R., Davis, S. R., Miller, K. K., Murad, M. H., Rosner, W., & Santoro, N. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2260 · Cited by 363
Cushing's syndrome: update on signs, symptoms and biochemical screening
Nieman, L. K. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0464 · Cited by 385
Self-citationHahner, S., Loeffler, M., Fassnacht, M., Weismann, D., Koschker, A.-C., Quinkler, M., Decker, O., Arlt, W., & Allolio, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0685 · Cited by 282
Feelders, R. A., Pulgar, S. J., Kempel, A., & Pereira, A. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1095 · Cited by 265
Webb, S. M., Badia, X. C., Barahona, M. J., Colao, A. A. L., Strasburger, C. J., Tabarin, A., van Aken, M. O., Pivonello, R., Stalla, G. K., Lamberts, S. W. J., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0762 · Cited by 228
BERTAGNA, X. Y., Guignat, L., Groussin, L., & Bertherat, J. Y. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.001 · Cited by 225
Cushing's syndrome: epidemiology and developments in disease management
Feelders, R., Sharma, S., & Nieman, L. (2015) · Clinical Epidemiology · doi:10.2147/clep.s44336 · Cited by 210
Self-citationOutcome of Bilateral Adrenalectomy in Cushing's Syndrome: A Systematic Review
Ritzel, K., Beuschlein, F., Mickisch, A., Oßwald, A., Schneider, H. J., Schopohl, J., & Reincke, M. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1470 · Cited by 201
Pivonello, R., De Martino, M. C., De Leo, M., Lombardi, G., & Colao, A. (2008) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.10.010 · Cited by 195
van der Klaauw, A. A., Kars, M., Biermasz, N. R., Roelfsema, F., Dekkers, O. M., Corssmit, E. P. M., van Aken, M. O., Havekes, B., Pereira, A. M., Pijl, H., et al. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03288.x · Cited by 176
Neuropsychiatric disorders in Cushing's syndrome
Pivonello, R., Simeoli, C., Martino, M. D. D., Cozzolino, A., de Leo, M., Iacuaniello, D., Pivonello, C., Negri, M., Pellecchia, M. T., Iasevoli, F., et al. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00129 · Cited by 116
Cushing’s disease: the burden of illness
Pivonello, R., Martino, M. D. D., de Leo, M., Simeoli, C., & Colao, A. (2017) · Endocrine · doi:10.1007/s12020-016-0984-8 · Cited by 153
Christ‐Crain, M., Kola, B., Lolli, F., Fekete, C., Seboek, D., Wittmann, G., Feltrin, D., Igreja, S., Ajodha, S. J., Harvey-White, J. D., et al. (2008) · The FASEB Journal · doi:10.1096/fj.07-094144 · Cited by 175
Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease
Jagannathan, J., Smith, R. K., DeVroom, H. L., Vortmeyer, A. O., Stratakis, C. A., Nieman, L. K., & Oldfield, E. H. (2009) · Journal of neurosurgery · doi:10.3171/2008.8.jns08339 · Cited by 167
Self-citationAndela, C. D., Scharloo, M., Pereira, A. M., Kaptein, A. A., & Biermasz, N. R. (2015) · Pituitary · doi:10.1007/s11102-015-0636-7 · Cited by 137
Psychiatric Symptoms in Patients with Cushing’s Syndrome: Prevalence, Diagnosis and Management
Vives, A. S., Resmini, E., Pascual, J. C., Crespo, I., & Webb, S. M. (2017) · Drugs · doi:10.1007/s40265-017-0735-z · Cited by 131
Pituitary Centers of Excellence
McLaughlin, N., Laws, E. R., Oyesiku, N. M., Katznelson, L. J., & Kelly, D. F. (2012) · Neurosurgery · doi:10.1227/neu.0b013e31826d5d06 · Cited by 117
Pivonello, R., Petersenn, S., Newell-Price, J. D. C., Findling, J. W., Gu, F., Maldonado, M., Trovato, A., Hughes, G., Salgado, L. R., Lacroix, A., et al. (2014) · Clinical Endocrinology · doi:10.1111/cen.12431 · Cited by 117
Ragnarsson, O., Berglund, P., Eder, D. N., & Johannsson, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1945 · Cited by 111
Storr, H. L., Alexandraki, K., Martin, L., Isidori, A. M., Kaltsas, G., Monson, J. P., BESSER, G. M., Matson, M. B., Evanson, J., Afshar, F., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-1120 · Cited by 108
Little, A. S., Kelly, D. F., Milligan, J., Griffiths, C. F., Prevedello, D. M., Carrau, R. L., Rosseau, G. L., Barkhoudarian, G., Otto, B. A., Jahnke, H. K., et al. (2015) · Journal of neurosurgery · doi:10.3171/2014.10.jns141624 · Cited by 106
Endoscopic skull base surgery and its impact on sinonasal‐related quality of life
McCoul, E. D., Anand, V. K., Bedrosian, J. C., & Schwartz, T. H. (2012) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21008 · Cited by 103
Psychosomatic aspects of Cushing’s syndrome
Sonino, N., Fallo, F., & Fava, G. (2010) · Reviews in Endocrine & Metabolic Disorders · doi:10.1007/s11154-009-9123-7 · Cited by 38
Comorbidities in Cushing’s disease
Sharma, S. T., Nieman, L. K., & Feelders, R. A. (2015) · Pituitary · doi:10.1007/s11102-015-0645-6 · Cited by 141
Self-citationWagenmakers, M. A. E. M., Netea-Maier, R. T., Prins, J. B., Dekkers, T., den Heijer, M., & Hermus, A. R. M. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0308 · Cited by 101
Evaluation of depression, quality of life and body image in patients with Cushing’s disease
Alçalar, N., Ozkan, S., Kadıoğlu, P., Celik, O., Çağatay, P., Küçükyürük, B., & Gazioğlu, N. (2012) · Pituitary · doi:10.1007/s11102-012-0425-5 · Cited by 93
Long‐term morbidity and mortality in patients with Cushing's syndrome
Braun, L., Vogel, F., & Reincke, M. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13113 · Cited by 93
Bilateral Adrenalectomy for Refractory Cushing Disease: A Safe and Definitive Therapy
Smith, P. W., Turza, K. C., Carter, C. O., Vance, M. L., Laws, E. R., & Hanks, J. B. (2009) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2009.02.054 · Cited by 87
Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications
Arnaldi, G., Mancini, T., Tirabassi, G., Trementino, L., & Boscaro, M. (2012) · Journal of Endocrinological Investigation · doi:10.1007/bf03345431 · Cited by 85
Cushing's syndrome: aftermath of the cure
Pivonello, R., De Martino, M. C., De Leo, M., Tauchmanovà, L., Faggiano, A., Lombardi, G., & Colao, A. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800025 · Cited by 85
Quality of life is decreased in female patients treated for microprolactinoma
Kars, M., van der Klaauw, A. A., Onstein, C. S., Pereira, A. M., & Romijn, J. A. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0259 · Cited by 70
Fleseriu, M., Molitch, M., Gross, C., Schteingart, D., Vaughan, T. B., & Biller, B. (2013) · Endocrine Practice · doi:10.4158/ep12149.ra · Cited by 55
Psychiatric and neurocognitive consequences of endogenous hypercortisolism
Piasecka, M., Papakokkinou, E., Valassi, E., Vives, A. S., Webb, S. M., de Vries, F., Pereira, A. M., & Ragnarsson, Ó. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13056 · Cited by 71
Assessment of health surveys: fitting a multidimensional graded response model
Depaoli, S. A., Tiemensma, J., & Felt, J. M. (2018) · Psychology Health & Medicine · doi:10.1080/13548506.2018.1447136 · Cited by 66
Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission
Schernthaner-Reiter, M. H., Siess, C., Gessl, A., Scheuba, C., Wolfsberger, S., Riss, P., Knosp, E., Luger, A., & Vila, G. (2019) · Endocrine · doi:10.1007/s12020-018-1819-6 · Cited by 60
Clinical consequences of Cushing’s syndrome
Valassi, E., Crespo, I., Vives, A. S., & Webb, S. M. (2012) · Pituitary · doi:10.1007/s11102-012-0394-8 · Cited by 60
Valassi, E., Feelders, R. A., Maiter, D. M., Chanson, P., Yaneva, M., Reincke, M., Kršek, M., Tóth, M., Webb, S. M., Vives, A. S., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13600 · Cited by 59
Management of hyperglycaemia in Cushing's disease: Experts’ proposals on the use of pasireotide
Reznik, Y., Bertherat, J. Y., Borson‐Chazot, F., Brue, T. C., Chanson, P., Cortet‐Rudelli, C., Delemer, B., Tabarin, A., Bisot-Locard, S., & Vergès, B. L. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.10.005 · Cited by 59
Keil, M. F., Merke, D. P., Gandhi, R., Wiggs, E. A., Obunse, K., & Stratakis, C. A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03515.x · Cited by 56
Psychometric performance of the CushingQoL questionnaire in conditions of real clinical practice
Vives, A. S., Resmini, E., Martínez-Momblán, M.-A., Crespo, I., Valassi, E., Roset, M., Badia, X. C., & Webb, S. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0325 · Cited by 55
Fredman, R., & Tenenhaus, M. (2012) · Burns · doi:10.1016/j.burns.2012.09.020 · Cited by 55
León-Justel, A., Madrazo-Atutxa, A., Alvarez-Rios, A. I., Infantes-Fontán, R., Garcia-Arnés, J. A., Lillo-Muñoz, J. A., Aulinas, A., Urgell-Rull, E., Boronat, M., Sánchez-de-Abajo, A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1673 · Cited by 52
Long-term consequences of Cushing syndrome: a systematic literature review
Puglisi, S., Perini, A. M. E., Botto, C., Oliva, F., & Terzolo, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad453 · Cited by 53
Pituitary adenomas and neuropsychological status: a systematic literature review
Pertichetti, M., Serioli, S., Belotti, F., Mattavelli, D., Schreiber, A., Cappelli, C., Padovani, A., Gasparotti, R., Nicolai, P., Fontanella, M. M., et al. (2019) · Neurosurgical Review · doi:10.1007/s10143-019-01134-z · Cited by 52
Alobid, I., Enseñat, J., Mariño-Sánchez, F., Rioja, E., de Notaris, M., Mullol, J., & Bernal-Sprekelsen, M. (2013) · American Journal of Rhinology & Allergy · doi:10.2500/ajra.2013.27.3932 · Cited by 61
Ragnarsson, Ó., & Johannsson, G. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0534 · Cited by 51
Psychosocial impairment in patients treated for pituitary disease: a controlled study
Sonino, N., Ruini, C., Navarrini, C., Ottolini, F., Sirri, L., Paoletta, A., Fallo, F., Boscaro, M., & Fava, G. A. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02951.x · Cited by 51
Karabatsou, K., O'Kelly, C. J., Ganna, A. A., Dehdashti, A. R., & Gentili, F. (2008) · British Journal of Neurosurgery · doi:10.1080/02688690802220379 · Cited by 50
Frimodt-Møller, K. E., Jepsen, J. R. M., Feldt‐Rasmussen, U., & Krogh, J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00749 · Cited by 50
Quality of Life in Patients With Cushing's Disease
Vives, A. S., Resmini, E., Martínez-Momblán, M.-A., Valassi, E., Martel‐Duguech, L., & Webb, S. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00862 · Cited by 48
Quality of Life in Patients with Skull Base Tumors: Current Status and Future Challenges
Gil, Z., & Fliss, D. M. (2010) · Skull base · doi:10.1055/s-0029-1242979 · Cited by 47
Ragnarsson, O., Mattsson, A. F., Monson, J. P., Filipsson Nyström, H., Åkerblad, A.-C., Kołtowska-Häggström, M., & Johannsson, G. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0397 · Cited by 46
Valizadeh, M., Ahmadi, A. R., Ebadinejad, A., Rahmani, F., & Abiri, B. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09723-y · Cited by 47
Global clinical response in C ushing's syndrome patients treated with mifepristone
Katznelson, L. J., Loriaux, D. L., Feldman, D., Braunstein, G. D., SCHTEINGART, D. E., & Gross, C. (2013) · Clinical Endocrinology · doi:10.1111/cen.12332 · Cited by 45
Stewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 45
Findling, J. W., & Raff, H. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.015 · Cited by 43
Long-term cognitive effects of glucocorticoid excess in Cushing’s syndrome
Forget, H., Lacroix, A., Bourdeau, I., & Cohen, H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.020 · Cited by 42
Broersen, L. H. A., Andela, C. D., Dekkers, O. M., Pereira, A. M., & Biermasz, N. R. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01054 · Cited by 42
Chan, L. F., Storr, H. L., Plowman, P. N., Perry, L. A., BESSER, G. M., Grossman, A. B., & Savage, M. O. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0588 · Cited by 42
The degree of urinary hypercortisolism is not correlated with the severity of cushing’s syndrome
Guarnotta, V., Amato, M. C., Pivonello, R., Arnaldi, G., Ciresi, A., Trementino, L., Citarrella, R., Iacuaniello, D., Michetti, G., Simeoli, C., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0914-9 · Cited by 43
Dimopoulou, C., Ising, M., Pfister, H., Schopohl, J., Stalla, G. K., & Sievers, C. (2012) · Neuroendocrinology · doi:10.1159/000338408 · Cited by 43
Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease
van der Pas, R., de Bruin, C., Pereira, A. M., Romijn, J. A., Netea-Maier, R. T., Hermus, A. R., Zelissen, P. M., de Jong, F. H., van der Lely, A. J., de Herder, W. W., et al. (2013) · Pituitary · doi:10.1007/s11102-012-0452-2 · Cited by 39
Psychometric Evaluation of the Cushing’s Quality-of-Life Questionnaire
Nelson, L. M., Forsythe, A., McLeod, L., Pulgar, S. J., Maldonado, M., Coles, T., Zhang, Y., Webb, S. M., & Badia, X. C. (2013) · Patient · doi:10.1007/s40271-013-0012-5 · Cited by 39
Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome
Vives, A. S., Resmini, E., Gómez‐Ansón, B., Crespo, I., Granell, E., Valassi, E., Pires, P., Vives‐Gilabert, Y., Martínez-Momblán, M.-A., de Juan-Delago, M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0600 · Cited by 38
Valassi, E., Crespo, I., Keevil, B. G., Aulinas, A., Urgell, E., Vives, A. S., Trainer, P. J., & Webb, S. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0779 · Cited by 39
de Bucy, C., Guignat, L., Niati, T., Bertherat, J. Y., & Coste, J. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0048 · Cited by 37
Quality of life in patients with pituitary tumors
Vives, A. S., Resmini, E., Martínez-Momblán, M.-A., Martí, C., Ybarra, J., & Webb, S. M. (2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32832cdec9 · Cited by 37
Milian, M., Teufel, P., Honegger, J. B., Gallwitz, B., Schnauder, G., & Psaras, T. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04191.x · Cited by 36
Quality of life is significantly impaired in both secretory and non‐functioning pituitary adenomas
Vega‐Beyhart, A., Enriquez-Estrada, V. M., Bello‐Chavolla, O. Y., Victoria, T. R. T., Martínez‐Sánchez, F. D., López-Navarro, J. M., Perez‐Guzman, M. C., Hinojosa‐Amaya, J. M., León‐Suárez, A., Espinosa-Salazar, H. D., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13915 · Cited by 36
Circadian Blood Pressure Profile in Patients with Active Cushing's Disease and after Long-term Cure
Giraldi, F. P., Toja, P. M., Martin, M., Maronati, A., Scacchi, M., Omboni, S., Cavagnini, F., & Parati, G. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-992813 · Cited by 37
Vision-Related Quality of Life after Transsphenoidal Surgery for Pituitary Adenoma
Okamoto, Y., Okamoto, F., Yamada, S., Honda, M., Hiraoka, T., & Oshika, T. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3763 · Cited by 34
A specific nursing educational program in patients with Cushing’s syndrome
Martínez-Momblán, M.-A., Gómez, C. C., Vives, A. S., Porta, N., Esteve, J., Bonet, I. Ú., Halperín, I., Campillo, B., Guillaumet, M., Webb, S. M., et al. (2015) · Endocrine · doi:10.1007/s12020-015-0737-0 · Cited by 35
Chan, L. F., Vaidya, M., Westphal, B., Allgrove, J., Martin, L., Afshar, F., Hindmarsh, P. C., Savage, M. O., Grossman, A. B., & Storr, H. L. (2011) · Hormone Research in Paediatrics · doi:10.1159/000324419 · Cited by 36
Höybye, C., Ragnarsson, Ó., Jönsson, P., Kołtowska‐Häggström, M., Trainer, P. J., Feldt‐Rasmussen, U., & Biller, B. M. K. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0836 · Cited by 34
Criteria of cure and remission in Cushing's disease: an update
Czepielewski, M. A., Rollin, G., Casagrande, A., & Ferreira, N. P. D. F. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800023 · Cited by 34
Rehabilitation in Endocrine Patients: A Novel Psychosomatic Approach
Sonino, N., & Fava, G. A. (2007) · Psychotherapy and Psychosomatics · doi:10.1159/000107558 · Cited by 33
Suberman, T. A., Zanation, A. M., Ewend, M. G., Senior, B. A., & Ebert, C. S. (2011) · International Forum of Allergy & Rhinology · doi:10.1002/alr.20029 · Cited by 33
Quality of life in Cushing's syndrome.
Bride, M., Crespo, I., Webb, S., & Valassi, E. (2021) · Best practice & research. Clinical endocrinology & metabolism · doi:10.1016/j.beem.2021.101505 · Cited by 19
Ritvonen, E., Karppinen, A., Sintonen, H., Vehkavaara, S., Kivipelto, L., Roine, R. P., Niemela, M. R., & Schalin‐Jäntti, C. (2014) · Clinical Endocrinology · doi:10.1111/cen.12550 · Cited by 32
Mifepristone: is there a place in the treatment of Cushing’s disease?
Carmichael, J., & Fleseriu, M. (2013) · Endocrine · doi:10.1007/s12020-012-9846-1 · Cited by 27
Psaras, T., Milian, M., Hattermann, V., Will, B. E., Tatagiba, M. S., & Honegger, J. B. (2011) · PubMed · doi:10.3275/7333 · Cited by 31
Morbidity of Cushing’s Syndrome and Impact of Treatment
Webb, S. M., & Valassi, E. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.01.001 · Cited by 31
Milian, M., Honegger, J. B., Gerlach, C., & Psaras, T. (2013) · Acta Neurochirurgica · doi:10.1007/s00701-013-1809-7 · Cited by 30
Vives, A. S., Granell, E., Gómez‐Ansón, B., Crespo, I., Pires, P., Vives‐Gilabert, Y., Valassi, E., Webb, S. M., & Resmini, E. (2017) · BioMed Research International · doi:10.1155/2017/2061935 · Cited by 31
Cushing’s syndrome: an update on current pharmacotherapy and future directions
Creemers, S. G., Hofland, L. J., Lamberts, S. W. J., & Feelders, R. A. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1061995 · Cited by 30
Webb, S. M., Ware, J. E., Forsythe, A., Yang, M., Badia, X. C., Nelson, L. M., Signorovitch, J., McLeod, L., Maldonado, M., Zgliczyński, W., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1013 · Cited by 29
Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy
Dineen, R., Stewart, P. M., & Sherlock, M. (2019) · Clinical Endocrinology · doi:10.1111/cen.13837 · Cited by 30
Mental Fatigue and Executive Dysfunction in Patients with Cushing’s Syndrome in Remission
Papakokkinou, E., Johansson, B., Berglund, P., & Ragnarsson, Ó. (2015) · Behavioural Neurology · doi:10.1155/2015/173653 · Cited by 29
Predictors of resource utilization in transsphenoidal surgery for Cushing disease
Little, A. S., & Chapple, K. M. (2013) · Journal of neurosurgery · doi:10.3171/2013.1.jns121375 · Cited by 28
Mapping CushingQoL Scores onto SF-6D Utility Values in Patients with Cushing’s Syndrome
Roset, M., Badia, X. C., Forsythe, A., & Webb, S. M. (2013) · Patient · doi:10.1007/s40271-013-0010-7 · Cited by 28
An Individualized Approach to the Evaluation of Cushing Syndrome
Sharma, S. T. (2017) · Endocrine Practice · doi:10.4158/ep161721.ra · Cited by 28
Cushing Syndrome Associated Myopathy: It Is Time for a Change
Reincke, M. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1069 · Cited by 31
Polycystic ovarian syndrome and Cushing's syndrome: a persistent diagnostic quandary
Brzana, J. A., Yedinak, C. G., Hameed, N., Plesiu, A., McCartney, S., & Fleseriu, M. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.12.038 · Cited by 28
Quality of Life After Endoscopic Surgical Management of Pituitary Adenomas
Castle‐Kirszbaum, M., Wang, Y. Y., King, J., & Goldschlager, T. (2021) · Neurosurgery · doi:10.1227/neu.0000000000001740 · Cited by 27
Clinical and biochemical manifestations of Cushing’s
Ntali, G., Grossman, A. B., & Karavitaki, N. (2015) · Pituitary · doi:10.1007/s11102-014-0631-4 · Cited by 27
Metadata
- Authors
- Lindsay, J. R., Nansel, T., Baid, S., Gumowski, J., & Nieman, L. K.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Nieman, Lynnette K.
- ORCID
- Nieman, Lynnette K.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-02
- Volume
- 91
- Issue
- 2
- Pages
- 447-453
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2149619533
- Cited by
- 210
- References
- 24
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 3 · 2023: 6 · 2022: 14 · 2021: 9 · 2020: 4 · 2019: 8 · 2018: 12 · 2017: 9 · 2016: 13 · 2015: 22 · 2014: 14 · 2013: 16 · 2012: 20
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's syndrome, Cushing's disease, health-related quality of life, transsphenoidal surgery, surgical remission, long-term outcomes, physical function, mental health, glucocorticoid use, residual impairment
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Cross-Sectional Studies, Cushing Syndrome, Female, Humans, Male, Middle Aged, Prospective Studies, Quality of Life, Surveys and Questionnaires, Remission Induction, Cohort Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review